Speaker Profile
Ph.D., Director of Business Development, NuProbe
Biography
Nicolas Garreau de Loubresse, Ph.D., serves as Director of Business Development for NuProbe, USA. Previously, he was a Research Fellow at the Wyss Institute at Harvard University and a Business Development Fellow at Harvard Office of Technology Development. He is also the co-founder of Urania Therapeutics and inventor of Urania’s core technologies. He published first-author articles in Science and Nature, and received competitive fellowships (EMBO, HFSP) and awards (AXA-French Academy of Science).
Clinical & Research Tools Showcase:
NuProbe
NuProbe accelerates technology innovation in precision diagnostics to enable diseases to be detected, treated and cured earlier for better outcomes with lower costs.
Ultra-sensitive Biomarker Assay Development for Translational Research & Precision Medicine
- Biomarker detection strategies with best-in-class sensitivity from solid tumor and liquid biopsy
- From research use only to clinical trial; assay development and validation, clinical specimen testing, and manufacturing services
- Insights into NuProbe's assay development programs addressing challenging translational research questions
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
